Bisebromoamide

General Information


DRACP ID  DRACP04223

Peptide Name   Bisebromoamide

Sequence  AXXlXX

Sequence Length  6

UniProt ID  Not available

PubChem CID  Not available

Origin  Bacteria

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  PivOH

C-terminal Modification  Free

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C3H-3NO-3

Absent amino acids  CDEFGHIKLMNPQRSTVWY

Common amino acids  X

Mass  52838

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  1

Net charge  0

Boman Index  181

Hydrophobicity  30

Aliphatic Index  16.67

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 19803465

Title  Bisebromoamide, a potent cytotoxic peptide from the marine cyanobacterium Lyngbya sp: isolation, stereostructure, and biological activity

Doi Not available

Year  2009

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  18509

DRACP is developed by Dr.Zheng's team.